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Abstract
Cholinergic signaling plays an important role in regulating the
growth and regeneration of axons in the nervous system. The
a7 nicotinic receptor (a7) can drive synaptic development and
plasticity in the hippocampus. Here, we show that activation of
a7 significantly reduces axon growth in hippocampal neurons
by coupling to G protein-regulated inducer of neurite outgrowth
1 (Gprin1), which targets it to the growth cone. Knockdown of
Gprin1 expression using RNAi is found sufficient to abolish the
localization and calcium signaling of a7 at the growth cone.
In addition, an a7/Gprin1 interaction appears intimately linked
to a Gao, growth-associated protein 43, and CDC42 cytoskel-
etal regulatory pathway within the developing axon. These
findings demonstrate that a7 regulates axon growth in hippo-
campal neurons, thereby likely contributing to synaptic forma-
tion in the developing brain.
Keywords: axon growth, choline, cytoskeleton, G protein-
regulated inducer of neurite outgrowth, hippocampus, synaptic
maturation.
J. Neurochem. (2014) 129, 649–662.
In the adult nervous system, neurotransmitters play a central
role in driving communication between neurons. In the
developing nervous system, neurotransmitters such as sero-
tonin and acetylcholine (ACh) contribute to various phases of
development including neurogenesis, cell differentiation, and
the formation of synapses (Erskine and McCaig 1995;
Rudiger and Bolz 2008). The cerebral cortex and hippocam-
pus receive ACh innervation from the basal forebrain, medial
septum, and vertical diagonal band (Bruel-Jungerman et al.
2011). Beginning prenatally and continuing through early
adulthood, the cholinergic signal informs neural connectivity
by modulating the growth and retraction of axons (Elsas
et al. 1995; Luo and O’Leary 2005) and the formation of
local dendritic fields within hippocampal neurons (Campbell
et al. 2010; Lozada et al. 2012).
Cholinergic signaling is dependent on the activation of the
G protein-coupled muscarinic receptor and nAChRs (Jones
et al. 2012). In the adult hippocampus, a7 is expressed pre-
and post-synaptically, contributing to GABA and glutamate
neurotransmission (Liu et al. 2006; Lozada et al. 2012).
Although studies show that a7 regulates neural development
in the cortex and hippocampus (Coronas et al. 2000; Liu
et al. 2006; Lozada et al. 2012), its mechanism of action is
ill defined.
Several nAChRs have been found to interact with G
proteins and contribute to intracellular signaling in neurons
(Fischer et al. 2005; Kabbani 2007; Paulo et al. 2009;
Nordman and Kabbani 2012). Recently, we have shown that
coupling to a G protein complex consisting of G protein-
regulated inducer of neurite outgrowth 1 (Gprin1), the
heterotrimeric GTP-binding subunit Gao, and growth-asso-
ciated protein 43 (GAP-43) enables a7 to regulate neurite
growth (Nordman and Kabbani 2012). To determine the role
of a7 in brain development, we have examined the effect of
a7/Gprin1 interaction in cultured hippocampal neurons. We
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find that a7 activation contributes to calcium signaling and
inhibition of axon growth via a Gprin1 pathway.
Materials and methods
Neuronal cultures, transfection, and drug treatment
Primary hippocampal neurons were obtained from post-natal day 1
(P1) male and female Sprague–Dawley rats (Charles River,
Frederick, MD, USA) as described (Nunez 2008) in accordance
with the Institutional Animal Care and Use Committee (IACUC)
and ARRIVE guidelines. Neuronal cultures were grown in Neuro-
basal media with B27 supplement and 1% Pen-strep. Serum was
withdrawn 12 h after plating to minimize glial growth. A knock-
down in a7 expression (a7-) was obtained by transducing high-titer
lentiviral stocks of short hairpin RNAs representing a7 RNAi
(Lozada et al. 2012) into hippocampal neurons. A scrambled a7
RNAi was used as a transduction control (Lozada et al. 2012).
Knockdown in Gprin1 expression (Gprin1-) was obtained by
transfecting Gprin1 siRNA in pRNAT H1.1 into hippocampal
neurons. Gprin1 vectors have been described previously (Ge et al.
2009; Nordman and Kabbani 2012). Neurons were transfected using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Unless
otherwise stated, an empty plasmid corresponding to the transfected
protein vector was used as a control in the assay.
Drug concentrations were determined based on published studies
(Chan and Quik 1993; Strittmatter et al. 1994; Swarzenski et al.
1996; Khiroug et al. 2002; El Kouhen et al. 2009): a-Bungarotoxin
(Bgtx) (50 nM, Sigma, St Louis, MO, USA); PNU282987 (PNU)
(1–10 lM, Sigma); pertussis toxin (Ptx) (1 lM, Calbiochem, San
Diego, CA, USA); mastoparan (30 lM, Tocris, Bristol, UK); and
choline (1 mM, Acros, Geel, Belgium). Drug treatment experiments
were performed in triplicate and the data presented represent the
average for each condition. Prior to initiation of the assay, the effect of
drug concentration on cell viability and health was pre-established
using trypan blue (EMD).
Immunochemical detection of proteins in brain slices
and cultured cells
Hippocampal brain slice preparation and immunohistochemistry
were preformed as described in Lozada et al. (2012). Briefly, P5
and P30 rats were anesthetized using 5% isofluorane and then
perfused using 4% paraformaldehyde, pH 7.2. Brains were
dissected and submerged in 4% paraformaldehyde for 24 h before
being transferred to 30% sucrose for cryoprotection. The tissue
was then embedded in 5% agarose and sectioned into 30-lm slices
using a vibrating blade microtome (Thermo Scientific, Waltham,
MA, USA). For immunohistochemistry, brain slices were permea-
bilized using 0.5% Triton X-100 and quenched by 50-mM
ammonium chloride for 30 min at 25°C. Tissue was blocked in
10% goat serum prior to being probed with the a7 ligand
fluorescein-conjugated Bgtx (fBgtx) (Molecular Probes, Eugene,
OR, USA), a polyclonal rabbit anti-Gprin1 antibody (Ab) (Abcam,
Cambridge, MA, USA), and a polyclonal mouse anti-Tau-1 Ab
(Millipore, Billerica, MA, USA) overnight at 4°C. Tissue was
reblocked in 10% goat serum followed by immunoprobing with a
Dylight 560 secondary anti-rabbit Ab and an Alexafluor 647
secondary anti-mouse Ab for Gprin1 and Tau-1 detection,
respectively (Jackson-ImmunoResearch, West Grove, PA, USA).
Background autofluorescence was accounted for using the second-
ary Ab alone.
Cellular immunostaining was carried out as described in He et al.
(2005). Briefly, cultured neurons were fixed in 19 PEM (80 mM
PIPES, 5 mM EGTA, and 1 mM MgCl2, pH 6.8) containing 0.3%
glutaraldehyde, and then permeabilized at 25°C in 0.05% Triton X-
100 prior to glutaraldehyde quenching with 10 mg/mL sodium
borohydride. Cells were blocked in 10 mg/mL bovine serum albumin
+ 10% goat serum prior to being immunostained overnight at 4°C
with the following primary Abs: mouse anti-Tau-1; anti-Gprin1;
pGAP-43; GTP-CDC42 (New East, King of Prussia, PA, USA).
Secondary Abs used (all purchased from Jackson-ImmunoResearch):
carbocyanine (Cy) 2/3; Dylight 488; Dylight 560; and AlexaFluor
647. a7 was visualized using fBgtx. F-actin was visualized using
Rhodamine Phalloidin (Cytoskeleton). All staining was visualized
using a Nikon Eclipse 80i confocal microscope (Melville, NY, USA)
fitted with a Nikon C1 CCD camera and images were captured using
AxioVision and EZ-C1 software (Thornwood, NY, USA).
For protein distribution analysis in immunostainings, brain slices
and cells in culture were analyzed for co-localization and distribu-
tion of a7 and Gprin1 by first thresholding the individual signals to
reduce background (Lozada et al. 2012) and then merging the two
signals using ImageJ (NIH, Bethesda, MD, USA). For brain slices,
the colocalized a7/Gprin1 signal was measured in various compart-
ments according to overlap with DIC. Distribution analysis was
conducted by measuring the signal within a 1 lm2 area for neurons
or a 25 lm2 area for brain slices sufficient for analysis at the single
neuron level. Analysis was conducted in Tau-1 positive (Tau-1+)
cultured hippocampal neurons. All data are based on averages from
three separate independent experiments.
Protein isolation and detection
Solubilized membrane protein fractions (membrane proteins) of
hippocampal cells were obtained using a published protocol
optimized for nAChRs (Kabbani et al. 2007). Immunoprecipitation
(IP) of receptor–protein complexes for a7 was optimized and
described previously (Nordman and Kabbani 2012). In brief,
proteins were solubilized overnight at 4°C using a solution of 1%
Triton X-100, 137 mM NaCl, 2 mM EDTA, and 20 mM Tris-HCl
(pH 8) with a 19 protease inhibitor cocktail (Complete, Roche,
Indianapolis, IN, USA) and a 19 phosphatase inhibitor cocktail
(Sigma). Protein concentrations were obtained using the Coomassie
Protein Assay reagent (Thermo Scientific). IP experiments were
performed by first incubating membrane proteins with an anti-a7
monoclonal Ab (mAb306; Lindstrom et al. 1990) or an anti-Gprin1
rabbit polyclonal Ab (Abcam) followed by extraction using protein
G Dynabeads (Invitrogen). Control IP experiments were performed
by incubating the same amount of membrane proteins (MP, 100 lg)
with an equal amount of a pure polyclonal rabbit IgG Ab (5 lg)
(Cell Signaling Technology, Beverly, MA, USA).
Western blot detection was obtained using nitrocellulose mem-
branes blocked with 5% non-fat milk (or 1% bovine serum albumin
for biotinylation experiments). Membranes were probed with the
following primary Abs overnight at 4°C: a7 nAChR (SC); Gprin1;
HCN1 (SC); GAP-43 (Abcam); pGAP-43; CDC42 (SC); GTP-
CDC42; glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(Cell Signaling). Species-specific peroxidase-conjugated secondary
Abs were purchased from Jackson-Immunoresearch. Signals were
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detected using the SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific) with SeeBlue and MagicMark (Invi-
trogen) as molecular weight standards. Blots were imaged using the
Gel Doc Imaging system (Bio-Rad Laboratories, Hercules, CA,
USA). Band density analysis was performed using ImageJ version
10.2 (NIH). Western blot values are based on averages from three
separate independent experiments.
Growth cone purification
The growth cone (GC) fraction was prepared as described in Lohse
et al. (1996). In brief, hippocampi pooled from a litter of P0 rat pups
were homogenized in 1-mM TES buffer (50 mM Tris-HCl, pH 8.0,
5 mM EDTA, 51 mM NaCl) supplemented with 1-mM MgCl2,
0.32-M sucrose, and protease (Complete) and phosphatase (Sigma)
inhibitors. The homogenate was spun at low-speed centrifugation
(1660 g) and the supernatant was collected then layered over a
sucrose gradient of 0.83 M and 1.0 M. Layered sample was then
centrifuged at 242 000 g for 40–60 min at 4°C. The GC fraction was
found at the 0.83-M interface, whereas the cell fraction was found at
the 0.83–1.0 M fraction. GC proteins were solubilized for membrane
protein enrichment using the method described earlier in this study.
Biotinylation of cell surface receptors
The quantification of proteins at the cell surface was conducted
using a biotinylation protocol (Kabbani et al. 2002; Hannan et al.
2008). In these experiments, 300 lg/mL EZ-Link Sulfo-NHS-LC-
Biotin (Pierce, Rockford, IL, USA) was used to label cell surface
proteins in living cells for 30 min at 4°C. The biotin reaction was
quenched using tris-buffered saline, and membrane proteins were
prepared as described previously (Kabbani et al. 2007). A neutra-
vidin agarose bead matrix (Pierce) was used to pull down
biotinylated proteins over a 30-lm pore size Snap Cap spin column
(Pierce). Proteins were detected using western blot as described
earlier. Biotin labeling was detected using horseradish peroxidase–
conjugated streptavidin (Cell Signaling). Experiments were per-
formed in triplicate and the data presented are the group averages.
Morphological and statistical analysis
Morphological reconstruction was performed using Neuromantic
software (Myatt et al. 2012). Tau-1+ axons were measured for
surface area (SA) and branch number to assess size and complexity
under various conditions. Only the primary axon was analyzed in
each neuron. Neurons were readily visualized by Tau-1+ staining,
and GCs were visualized by reactivity to rhodamine phalloidin.
Group averages were derived from three separate experiments with
20–30 cells in each set. Statistical analysis was conducted on raw
data of image tracing using Neuromantic. Statistical values have
been obtained using a Student’s t-test or one-way ANOVA. Asterisks
indicate statistical significance in a paired Student’s t-test, two-tailed
p value, *< 0.05; **< 0.01; ***< 0.001. Error bars indicate
standard error of the mean (SEM).
EB3 comet imaging
End-binding protein 3 (EB3) is a microtubule capping protein that
binds to the plus end of polymerized microtubules during periods of
assembly (Stepanova et al. 2003). Hippocampal neuronal cultures
were transfected with red fluorescent protein (RFP) conjugated EB3
and the indicated cDNA plasmids using Lipofectamine 2000 at 60 h
after plating (Liu et al. 2010). EB3 comet imaging was performed
24 h later. Images were captured 1 frame per sec for 2 min at 2 9 2
binning using AxioVision. The images were quantified for the
velocity of the comets that enter the growth cone filopodia (Nadar
et al. 2008). Cells were treated with PNU (1–10 lM), a combina-
tion of PNU 10 lM and 50 nM Bgtx, 0.1% dimethylsulfoxide
(DMSO) as vehicle control, or an empty vector as a transfection
control. The comet trajectories were traced in these experiments
using ImageJ software (NIH). Experiments were performed in
triplicate and the data presented are the group averages.
Calcium imaging
Calcium imaging was carried out as described previously (Del
Negro et al. 2011) with minor modifications. P0 hippocampal
neurons were cultured for 3 DIV before loading with the calcium
dye Fluo-8 AM (SC). Cultures were washed with Hank’s Balanced
Salt Solution (HBSS) and then incubated for 20 min at 25°C in a
dye-loading solution containing HBSS with 10-mM HEPES,
2.5-lM Fluo-8 AM, and 0.2% Pluronic acid F-127. Following
incubation, the cultures were again washed in fresh HBSS and then
immediately placed into a recording chamber perfused with artificial
cerebrospinal fluid at a rate of 1 mL/min. We imaged Fluo-8 AM-
labeled neurons using a fixed-stage Zeiss Axio Examiner A.1 with a
639/1.0 NA objective and a Rolera EMC2 camera (Q-Imaging,
Surrey, BC, Canada) imaged at 10 Hz. Phototoxicity was minimized
through the use of low-wavelength polarized light filters. Image
stacks were acquired at 70 Hz using a CCD camera (Andor
Technology, South Windsor, CT, USA). The following drugs and
their concentrations were diluted in artificial cerebrospinal fluid and
administered via a perfusion system at 1 mL/min: PNU (10 lM);
PNU and Bgtx (50 nM); choline (1 mM); choline and Bgtx. 0.1%
DMSO was used as a vehicle control. An empty RFP vector was
used as a transfection control. Regions of interest were analyzed
using ImageJ (NIH) and normalized as DF/F0. Regions of interest
were averaged over conditions. The data presented have been
normalized to controls.
Mass spectrometry
Protein analysis was conducted using liquid chromatography electro
spray ionization (LC-ESI) mass spectrometry (MS). Protein com-
plexes were prepared as described (Kaiser et al. 2008) and mass
spectrometry was carried out using a published protocol (de Luca
et al. 2009). Tandem mass spectra collected by Xcalibur
(version2.0.2, Thermo Scientific) were searched against the NCBI
rat protein database using SEQUEST (Bioworks software from
Thermo Scientific, version 3.3.1). The SEQUEST search results were
filtered using the following criteria: minimum X correlation (XC) of
1.9, 2.2, and 3.5 for 1+, 2+, and 3+ ions, respectively, andDCn > 0.1.
The protein score represents theXCwhere scores< 0.1were excluded
from the analysis and does not reflect the quantity of a protein in the
sample.
Results
a7 and Gprin1 interact in the developing hippocampus
a7 is expressed in the adult hippocampus where it can
modulate the activity of excitatory and inhibitory neurons
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(Albuquerque et al. 1996, 1998). In hippocampal develop-
ment, however, less is known about the expression and role
of a7. We examined the distribution of a7 in the hippocam-
pus at various stages of growth. Brains from post-natal day
(P) 5 and 30 rats were probed for a7 expression using
fluorescent-conjugated a-bungarotoxin (fBgtx). In addition,
we co-immunolabeled the brain slices with an anti-Gprin1
Ab, which selectively recognizes Gprin1 (Nordman and
Kabbani 2012). As shown in Fig. 1a, co-expression of fBgtx
and Gprin1 was detected in the developing hippocampus.
This expression, although widespread, was not ubiquitous. In
particular, the Gprin1 signal was found in cells that were
immunoreactive for the axon-specific marker Tau-1, whereas
fBgtx labeling was detected in Tau-1+ cells (Fig. 1b) as well
as those that exhibited immunoreactivity to the astrocytic
marker glial fibrillary acidic protein (data not shown). These
findings imply that whereas a7 expression in not limited to
neurons, Gprin1 expression is predominantly neuronal.
We compared the expression of the two proteins during
development. A fluorescence double signal (co-signal) for
fBgtx and anti-Gprin1 within the cell was measured as
previously described (Nordman and Kabbani 2012). In
preliminary experiments, the fBgtx signal was diminished
by the addition of PNU (1 and 10 lM), confirming the
specificity of the ligands on a7 (Figure S1). As shown in
Fig. 1a, the co-signal was more abundant during the early P5
stage of development. A quantitative assessment of the
fluorescence co-signal was used to determine a7/Gprin1 co-
expression in the hippocampus. As shown in Fig. 1a, a
noticeable a7/Gprin1 co-signal was detected in CA3 and
CA1 regions at P5. Immunolabeling with an anti-Tau-1 Ab
confirmed that over 95% of the cells that displayed an a7/
Gprin1 co-signal are neurons (Fig. 1b). Hippocampal neu-
rons are known to undergo apoptosis, maturation, and
synaptic pruning during early post-natal development
(Jordan et al. 1997; Riccomagno et al. 2012). a7/Gprin1
co-expression was also detected in other regions of the
hippocampus as well as the cortex and striatum (Fig. 1a).
Single-labeling experiments using fBgtx, anti-Tau-1, or anti-
Gprin1 antibodies produced a signal consistent with the
double- and triple-labeling results (data not shown).
Immunofluorescent findings indicate that a7/Gprin1
expression is highest after birth. To explore this, we
examined the levels of the two proteins in hippocampal
tissue by western blot. As indicted in Fig. 1c, the expression
of a7, within membrane fractions of the developing
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Fig. 1 a7 and G protein-regulated inducer of
neurite outgrowth 1 (Gprin1) interact in the
developing hippocampus. (a) Coronal slices of
brains obtained from P5 and P30 rats. Slices were
co-labeled with fBgtx and anti-Gprin1 Abs and
visualized throughout the hippocampus, with
prominent expression found in the CA3 region.
Quantification of the co-signal in various brain
regions is shown in the histogram. (b) Triple
labeling for Tau-1 (blue), fBgtx (green), and
Gprin1 (red) in CA3 at P5. Arrows point to co-
localization of fBgtx and Gprin1 in soma and
axons. (c) Western blot detection of a7 and
Gprin1 in membrane protein (MP) fractions of the
hippocampus. The same blot was used to probe
for a7, Gprin1, and GAPDH as a loading control.
(d) Western blot detection of a7 and Gprin1
interactions from P0 pups within immunopre-
cipitation (IP) experiments. In-gel digest confirms
the identity of a7 and Gprin1 in the IP (Table S1).
Top blot: a7; middle blot: Gprin1; bottom blot:
HCN1. MP 20%: membrane protein as 20% of IP
load (100 lg). IgG: IP control. IP yield: amount of
IP protein obtained as determined by the equation:
optical density (O.D.) of IP bands/OD of 100%
MP 9100.
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hippocampus, appeared to peak at 1 and 4 days after birth.
Similarly, the expression of Gprin1 displayed a consistent
expression profile, i.e., peaking after birth then sharply
declining to barely detectable levels in adulthood (Fig. 1c).
These results suggest a role for the two proteins in
hippocampal development.
Immunoprecipitation was used to validate interactions
between a7 and Gprin1 during hippocampal development.
MP derived from P5 rat pups were used to immunoprecipitate
Gprin1 and a7 proteins. The a7-specific Ab mAb306 and an
anti-Gprin1 Ab were then used to immunoprobe for Gprin1
and a7 in the IP, respectively. As shown in Fig. 1d,
immunoreactive bands for a7 and Gprin1 proteins were
detected in the IP experiments. The identity of the proteins
within the IP assay was also confirmed in parallel experiments
utilizingMS analysis (Table S1) and previously (Nordman and
Kabbani 2012). An hyperpolarization-activated cyclic nucle-
otide-gated channel type 1 (HCN1)-specific Ab was used as a
negative control in the IP experiment. As shown, neither of the
two IP Abs was found to co-IP HCN1 in the assay (Fig. 1d),
thus, supporting the specificity of the interaction between a7
and Gprin1 at the plasma membrane.
Localization of a7 and Gprin1 in axons and growth cones
We examined expression of endogenous a7 and Gprin1
proteins in developing hippocampal neurons. At 3 days
in vitro (DIV) hippocampal neurons extend axons capable of
detecting and reacting to various external growth signals
(Kater and Mills 1991). As shown in Fig. 2, a7 and Gprin1
proteins were detected within developing hippocampal
neurons using fBgtx and anti-Gprin1 Abs, respectively.
The specificity of the Gprin1 Ab was verified in preliminary
studies that showed a proportional decrease in the Gprin1 Ab
signal following transfection with Gprin1 siRNA (data not
shown). In particular, strong levels of a7 and Gprin1 co-
expression were observed in the soma, at neurite branch
points, and in the GC (Fig. 2a). Growth cones and branch
points are known to be active regions of growth and
retraction (Lowery and Van Vactor 2009). We find that
a7/Gprin1 co-localization is highest at these regions of active
growth suggestive of a role for the interaction in cytoskeletal
remodeling and axon development.
The axon growth cone consists of three main zones:
peripheral, transitional, and central. The central zone (CZ) is
located at the base of the GC, nearest to the axon, and is
composed of microtubules as well as various receptors and
organelles (Lowery and Van Vactor 2009). We find strong
co-localization of a7 and Gprin1 within the CZ and, in some
cases, the two proteins were detected in the filopodia of the
GC (Fig. 2b). A GC purification strategy (described in
Materials and Methods) (Lohse et al. 1996) was utilized to
confirm expression and interaction of a7 and Gprin1 in the
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Fig. 2 a7 and G protein-regulated inducer of
neurite outgrowth 1 (Gprin1) associate in the
growth cone. (a) Hippocampal neurons from P0
pups were cultured for 3 DIV. Neurons were
probed with fBgtx (green) and anti-Gprin1 Abs
(red) (top images). A heat map measure of the co-
signal (bottom image) shows the distribution and
co-localization of the two proteins in the growing
axon and GC. Co-localization was highest in the
soma, growth cone (GC), and branch points (BP)
(arrows). (b) Localization of the fBgtx and Gprin1
signals in the GC. CZ: central zone. (c) Protein
detection of a7 and Gprin1 within GC fraction
(GCF) obtained from P0 pups as described in
Materials and methods. Growth-associated protein
43 (GAP-43) is used as a marker for the GCF. Cell
fraction (CF). (d) An anti-a7 and anti-Gprin1 Ab
was used to immunoprecipitate (IP) a7 and Gprin1
proteins from the GCF. Western blot detection
confirms interaction of the two proteins. Protein
identity was also determined by in-gel digest mass
spectrometry (Table S2). IgG was used as an Ab
control.
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GC of the developing hippocampus. As shown in Fig. 2c, an
anti-GAP-43 Ab was used to confirm the isolation of the GC
compartment from hippocampal tissue. A western blot
analysis reveals that a7 as well as Gprin1 are present within
the GC consistent with our immunocytochemical finding.
The interaction between the two proteins within the IP was
also confirmed in parallel using MS analysis (Table S2). The
above experiments demonstrate an a7/Gprin1 interaction
within the GC of developing hippocampal neurons.
a7 regulates the structure of the growth cone and axon
a7 has been shown to regulate neurogenesis and dendritic as
well as axonal synaptic formation in the nervous system
(Bromberg et al. 2008b; Lozada et al. 2012). To examine the
role of this receptor in early axon growth of hippocampal
neurons, we examined the effect of the a7-specific agonist
PNU282987 (PNU) on axon size and structure in hippo-
campal neurons. PNU is a known agonist at the a7 receptor
site found to bind other nAChR ligands including Bgtx
(El Kouhen et al. 2009). The stability of PNU and its
resistance to neurotransmitter reuptake mechanisms make it
an ideal experimental tool when attempting to selectively
target a7. Newly formed axons were visualized using an
antibody for the axon-specific microtubule protein Tau-1. We
assessed the effects of PNU (1–10 lM) or a combination of
PNU (10 lM) and the a7-specific antagonist a-Bungarotoxin
(Bgtx) (50 nM) on axon growth. PNU treatment was
associated with a significant, dose-dependent (10 lM)
reduction in axon growth [42% ( 6%)], measured as
total SA and branching number [47% ( 7%)] (Fig. 3a). In
the presence of Bgtx, however, PNU did not significantly
alter the growth and complexity of the primary axon relative
to control-treated cells (Fig. 3a). Group significance was
observed between controls and PNU doses (1–10 lM) (SA:
F(2,30) = 4.85, p < 0.01; branch: F(2,30) = 6.12, p < 0.01).
These results reveal that pharmacological activation of
a7 reduces axon growth and branching in hippocampal
neurons.
GC dynamics are instrumental in guiding the developing
axon toward its final destination and have been shown to be a
useful measure of real-time growth (Zheng and Poo 2007). In
particular, the innervation of microtubules into filopodia
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correlate with the directionality of axonal growth (Lowery
and Van Vactor 2009). We find high levels of a7 expression
in the GC formation at the end of the primary axon branch
(Fig. 2a). We hypothesize a role for a7 in regulating axon
growth via the GC. To test this, we analyzed the structure of
the GC in hippocampal neurons treated with the a7 agonist
PNU (1–10 lM). We find a dose-dependent reduction in the
number of GCs for each neuron [44% ( 10%)] and a
reduction in filopodia number and size in each GC [53% (
11%)] following PNU treatment and compared with vehicle-
treated controls (Fig. 3b). Group significance was observed
between controls and PNU doses (1–10 lM) (GC#/cell:
F(2,30) = 5.13, p < 0.01; Filopodia#/GC: F(2,30) = 6.95,
p < 0.01). In PNU (10 lM)-treated cells, GC and axon
morphology were highly correlated (Table S3), suggesting
that a7 activation inhibits growth uniformly throughout
the cell. Similar to axon growth, Bgtx was found to
abolish the effects of PNU (10 lM) on GC structure and
number in a highly correlative manner (Fig. 3b, Table S3),
underscoring the specificity of the a7 signal in these
developmental effects.
To confirm the role of a7 in axon growth, hippocampal
neurons were transduced with a7 RNAi or a scramble
vector then analyzed for morphological changes in axon
growth in the absence of drug treatment. As shown in
Fig. 3c, cells expressing a7 RNAi (a7-) displayed signif-
icantly enhanced growth of axons [SA: +39.5% ( 9%);
branch number: +85.6% ( 10%)] and growth cones [GC
number/cell: +72.2% ( 16%); filopodia number/cell:
53.4% ( 11%)] compared with both the scramble
controls and non-transfected cells (Fig. 3a–c). The scram-
ble vector was found to have no effect on axon growth.
Similar findings were observed in hippocampal neurons
treated with 50-nM Bgtx showing that inhibition of a7
promotes axon growth (data not shown). In light of earlier
findings on PNU-mediated inhibition of axon growth,
the current data supports the hypothesis that inactivation of
a7 can augment neurite growth (Nordman and Kabbani
2012).
We observed the effects of PNU treatment on cytoskeletal
growth using the microtubule + end capping protein RFP-
EB3 (EB3 comets), which has been utilized in analyzing
real-time axon growth (Stepanova et al. 2003; Liu et al.
2010). As shown in Fig. 3d, at 1 lM of PNU treatment, EB3
comets velocity was noticeably diminished relative to
controls. At 10 lM of PNU, however, the velocity of the
EB3 comets was not only significantly attenuated but also
moved in a retrograde direction suggestive of growth cone
collapse. Group significance was observed between controls
and PNU doses (1–10 lM) (F(2,30) = 5.80, p < 0.01). The
addition of Bgtx was found to significantly attenuate the
effects of PNU treatment (10 lM) on EB3 comet velocity,
and restored the directionality of comet movement to
anterograde (Fig. 3d).
Gprin1 is critical for a7-mediated growth
Gprin1 can regulate neurite growth via its ability to bind and
regulate large G proteins such as Gao, as well as small G
proteins such as CDC42 (Chen et al. 1999; Nakata and
Kozasa 2005). We determined a role for Gprin1 in
a7-mediated axon growth in hippocampal neurons by transfect-
ing neurons with plasmids encoding short interfering RNA
(siRNA) (Gprin1-), which has been shown to reduce Gprin1
expression in neural cells (Ge et al. 2009). Consistent with
earlier findings, reduction in Gprin1 expression was associ-
ated with an overall decrease in neurite growth (Ge et al.
2009). When examining the effects of PNU on axon growth,
we found that PNU has no effect on axon morphology in
Gprin1- cells (Fig. 4a), suggesting that Gprin1 expression is
necessary for a7 function. We confirmed the involvement of
Gao in the a7/Gprin1 pathway. As shown in Fig. 4b,
treatment of cells with the Gao activator mastoparan (MSP)
was found to significantly enhance axon growth [axon SA:
31% ( 11%); branch #: 47% ( 4%); GC #/cell: 58%
( 5%); filopodia #/cell: 45% ( 4%)]. The effect of MSP
was found sufficient to override PNU-mediated inhibition of
axon growth suggesting that Gao operates downstream of
a7. We confirmed this by also examining the role of the Gai/
o inhibitor PTX on axon development. Ptx exposure was
associated with a significant reduction in axon growth [axon
SA: 34% (10%); branch #: 41% (7%); GC #/cell:
40% (6%); filopodia #/cell: 47% (8%)] and this effect
was not enhanced by PNU. Group significance was observed
between controls, MSP, MSP+PNU, Ptx, and Ptx+PNU
treated cells [SA: F(4,50) = 5.37, p < 0.01; Branch#:
F(4,50) = 12.36, p < 0.001; GC#/Cell: F(4,50) = 12.79,
p < 0.001; Filopodia#/Cell: F(4,50) = 14.01, p < 0.001],
suggesting that a7 operates in a Gai/o pathway.
a7 signaling at the GC regulates GAP-43 and CDC42
A number of signaling pathways have been shown to
regulate axon growth or direct its retraction by directing the
assembly of the cytoskeleton (Lowery and Van Vactor
2009). Studies demonstrate that activation of GAP-43 via its
phosphorylation at Ser41 is critical for axon growth and
branching (Kozma et al. 1997; Dent and Meiri 1998; Leu
et al. 2010). Similarly, the GTP activation of CDC42 (GTP-
CDC42) functions as an important indicator of GC function
(Kozma et al. 1997). Recently, we demonstrated that a7
activation regulates GAP-43 phosphorylation in neurites
(Nordman and Kabbani 2012), while other studies have
shown a role for Gprin1/Gao in the activation of CDC42 in
the growth cone (Nakata and Kozasa 2005). To test the role
of a7 signaling in GAP-43 and CDC42 activation, we
examined the effect of PNU (60-min treatment) on the
phosphorylation of GAP-43 and the levels of GTP-CDC42 in
hippocampal neurons. We find a significant reduction in
phospho-GAP-43 (pGAP-43) (Zakharov and Mosevitsky
2007) and active (GTP bound) CDC42 (Elbediwy et al.
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2012) levels in PNU-treated cells (Fig. 4c). Decrease in
pGAP-43 and GTP-CDC42 expression was especially pro-
nounced in the GC (Fig. 4d). The effect of PNU on GAP-43
phosphorylation and CDC42 activation was abolished in the
presence of Bgtx, suggesting that a7 can inhibit the function
of these two growth regulatory proteins.
Gprin1 localizes a7 to the growth cone
Gprin1 is a membrane anchored signaling protein that
localizes to regions where cytoskeletal remodeling demands
are high. In neural cells, Gprin1 can direct the formation of
neurites by regulating the function of CDC42 in the growth
cone (Nakata and Kozasa 2005). Because recent studies
suggest that Gprin1 can also contribute to receptor localiza-
tion at the cell surface (Ge et al. 2009; Nordman and
Kabbani 2012), we examined the role of Gprin1 in trafficking
and targeting a7 to the plasma membrane. As shown in
Fig. 5a and b, Gprin1- cells displayed a significant reduction
in the axonal structure, which was accompanied by a
noticeable reduction in fBgtx labeling in the GC. To
determine the role of Gprin1 in directing a7 to the plasma
membrane, cell surface biotinylation experiments were
performed in Gprin1- cells and empty vector (pRNAT
H1.1) transfected controls. As shown in Fig. 5c, on the basis
of the detection of biotinylated a7 proteins, we find a
significant reduction in a7 at the cell surface in Gprin1-
relative to controls. In both the GC and the MP fraction,
levels of biotinylated a7 proteins was reduced in Gprin1-
cells suggesting that Gprin1 plays an essential role in
localizing a7 to sites important for axon growth. In these
experiments, HCN1 cell surface expression was found
unaffected.
Detection of an a7 calcium signal in the growth cone
Multiple ion channels and receptors contribute to calcium
entry and signaling within the GC (Zheng and Poo 2007).
The temporal and spatial dynamics of calcium within the GC
contribute to the elongation, retraction, and turning of the
axon via the actions of molecules such as GAP-43 and
Gprin1, which regulate the cytoskeleton (Nakata and Kozasa
2005; Zheng and Poo 2007). We hypothesize that a7/Gprin1
interaction enables calcium signaling leading to cytoskeletal
remodeling in the developing axon. To test this we analyzed
a7-mediated calcium changes in hippocampal neurons using
the calcium indicator Fluo-8 (Hayes et al. 2012). 0.1%
DMSO was used as a vehicle control. The control by itself
did not appear to impact calcium levels in the cell (data not
shown). As shown in Fig. 6, PNU treatment was found to
promote an overall increase in calcium relative to the control
within the soma [+37% ( 11%)], the axon [+52%
( 14%)], and the central zone of the GC [+68%
( 17%)]. In particular, the intracellular calcium rise was
strongest within the CZ of the GC, a region that expresses an
abundant amount of a7 and Gprin1 (Fig. 2). In filopodia,
PNU treatment was also found to augment calcium levels by
24% ( 7%). The effect of PNU on intracellular calcium
levels was recovered to baseline at ~ 0.5 s. consistent with
data on a7 channel kinetics (Fayuk and Yakel 2004) (Fig. 6).
Choline can endogenously activate a7, thereby critically
contributing to brain development (Khiroug et al. 2002). We
confirmed the effects of a7 activation in hippocampal
neurons using (1 mM) choline, a concentration previously
found to physiologically activate the receptor (Khiroug et al.
2002). We found that choline increased intracellular calcium
levels but most significantly in the GC of the neuron (Fig. 7).
The effect of choline was blocked by Bgtx, underscoring the
specificity of this transmitter for a7. Interestingly choline
was found to have little to no effect on calcium levels in the
soma (Fig. 7a). The findings suggest that the effects of
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choline on a7 may be altered by differential mechanisms of
transmitter reuptake in various neuronal compartments
(Guermonprez et al. 2002). To confirm that choline and
PNU produce similar effects on axon growth, an analysis of
axon morphology and pGAP-43 levels was also determined
in response to choline. Axon development, GC branching,
and pGAP-43 levels were all significantly attenuated by
choline and this effect was also blocked by the addition of
Bgtx (Fig. 7). Taken together, the findings indicate that a7
activation mediates intracellular calcium signaling leading to
an inhibition in axon development.
To confirm the contribution of Gprin1 in a7-mediated
calcium entry into the growing hippocampal neurons,
Gprin1- cells were analyzed for the effect of PNU (Fig. 6)
and choline (Fig. 7). As shown in Fig. 6, knockdown of
Gprin1 expression is associated with a significant reduction
in the cell’s calcium responsiveness to PNU treatment
(19% ( 9%) in the soma; 25% ( 11%) in the axon;
and 53% ( 8%) in the CZ) relative to an empty plasmid
(pRNAT H1.1) control. Similar data was obtained with
choline treatment (Fig. 7), confirming the role of Gprin1 in
a7-mediated calcium signaling in the developing axon.
These findings also present a first ever demonstration of an
a7 calcium signal in the GC, and suggest that this cholinergic
signal contributes to the maturation of the axon.
Discussion
A new role for a7 in axon growth
In this study we define an interaction between a7 and Gprin1
and demonstrate that this interaction regulates axon growth
in hippocampal neurons. We present evidence on the
localization and signaling of a7 in GCs as supported by
histochemical and western blot detection of the receptor and
its interacting protein Gprin1 in developing hippocampal
neurons. By interacting with Gprin1, the localization of a7 in
the GC appears to enable cholinergic signals to regulate the
growth of the axon. Based on this evidence, the interaction of
the two proteins and their coupling to a downstream G
protein-signaling pathway is proposed to contribute to brain
development.
Interestingly, whereas this study demonstrates a role for
a7 in axon development, earlier work has shown that
knockdown of the a7 can decrease dendritic length and
branching in newborn neurons of the dentate gyrus
(Campbell et al. 2010; Liu et al. 2010). This suggests that
a7 may differentially contribute to axon and dendrite
development by interacting with scaffolding proteins such
as Gprin1, which can guide the expression of the receptor
to specific neuronal compartments. In this regard, the func-
tion of Gprin1 in localizing a7 activity in the developing
Gprin1-
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axon, may be paralleled by another, still unknown, protein
that can direct the receptor to dendrites (Campbell et al.
2010). In future studies, it will be important to examine the
proteomic interactions of a7 in maturing dendrites.
Activation of a7 causes local calcium elevation and
a collapse of the GC
The synaptic localization and high calcium permeability of
a7 enables it to influence diverse events, ranging from
modulation of transmitter release to synaptic plasticity
(McGehee et al. 1995; Gu and Yakel 2011). The expression
and function of a7 in the GC during axon maturation
appears dependent on interaction with Gprin1, which directs
the trafficking of the receptor to the cell surface and the
central zone. This positions a7 at sites where developmental
demands are high, and enables it to influence cytoskeletal
mechanisms of growth (Lowery and Van Vactor 2009). As
a consequence, a7-mediated elevations in intracellular
calcium can arrest axon growth as shown previously for
other calcium channels (Kater and Mills 1991; Henley and
Poo 2004). The a7-mediated calcium rise in the GC
communicates a ‘stop’ signal for the growing axon, which
is made possible by association with Gprin1 and modulation
of the Gao, GAP-43, and CDC42 pathway (Frey et al.
2000; Nakata and Kozasa 2005). This hypothesis is
supported by our observation that activation by a7 (by
PNU or choline) promotes dephosphorylation of GAP-43,
GTP hydrolysis of CDC42, and negatively influences EB3
microtubule comet velocity in the GC leading to its
collapse. Mechanistically this may be achieved via
a7-mediated calcium elevations into the GC which can
inactivate GAP-43 via calcium sensitive proteins such as
calpain (Zakharov and Mosevitsky 2007) and PP2B (Lyons
et al. 1994), leading to inhibition of Ga and CDC42 in the
axon (Bromberg et al. 2008a). It is interesting to consider
the possible effects of a7 on other downstream Rho-
GTPases involved in growth. RhoA has previously been
shown to inhibit axon growth and GC collapse, while Gao
can regulate RhoA activity (Bromberg et al. 2008a). Thus,
the ability of a7 to inhibit axon growth may involve the
regulation of other possible Rho-GTPases through interac-
tion with the G protein complex. In the long term, activation
of a7 is associated with a dramatic reduction in axon length
and branching complexity.
A functional a7 signal in the growing axon can play an
important role in early-life synaptic development (Luo and
O’Leary 2005). Defects in processes such as neurogenesis
and axon pruning can lead to pernicious axon growth
implicated in a number of developmental brain disorders
such as autism, epilepsy, and schizophrenia (Saugstad 2011;
Zhou et al. 2012). Recent findings linking the expression of
the a7 gene CHRNA7 to developmental disorders (Yasui
et al. 2011; Adams et al. 2012) highlights the role of this
receptor in brain development.
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